Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001104659-25-089564
- form_type
- 8-K
- ticker
- TRAW
- cik
- 0001130598
- company_name
- Traws Pharma, Inc.
- filed_at
- 2025-09-12T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:43.412230+00:00
- generated_at
- 2026-05-17T06:43:07.658107+00:00
- sec_items
- ["1.01", "2.01", "9.01"]
- event_type
- m_and_a
- sentiment
- neutral
- materiality_score
- 0.55
- calibrated_materiality_score
- 0.55
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001104659-25-089564
- json_url
- https://secwatch.observer/filing/0001104659-25-089564.json
- markdown_url
- https://secwatch.observer/filing/0001104659-25-089564.md
- text_url
- https://secwatch.observer/filing/0001104659-25-089564.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1130598/000110465925089564/0001104659-25-089564-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1130598/000110465925089564/tm2526017d1_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
NNE
Nano Nuclear acquires STS for up to $13M, adds nuclear logistics and $7.1M revenue
Nano Nuclear Energy Inc.
May 29, 2026, 6:30 AM ET
m_and_a
Items 1.01, 2.01, 3.02, 5.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
“STS Acquisition”). The closing of the STS Acquisition occurred on May 22, 2026 (the “Closing Date”). Pursuant
to the Purchase Agreement, the Buyer Parties agreed to pay up to $13.0 million in total consideration for STS, consisting of (i) approximately
$6.0 million in cash (the “Closing Cash Consideration”), subject to adjustment under certain conditions within 180
Filing page
SEC filing
BESS
Bimergen contributes 3 BESS projects to Cerberus JV; receives 7.5% equity + $1.18M cash
Bimergen Energy Corp
May 28, 2026, 9:28 AM ET
m_and_a
Items 1.01, 2.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
Pursuant to the Contribution Agreement, Emergen contributed 100% of its equity interests in three battery energy storage system (“BESS”) project companies (the “Project Companies”), to the JV Company.
Filing page
SEC filing
TMGI
TMGI acquires CSTI in all-stock deal, 50.6M shares issued
Transglobal Management Group, Inc.
May 27, 2026, 7:04 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
Exchange Agreement (the “Agreement”) to
acquire all of the outstanding shares of Continuum Software Technologies, Inc., a Wyoming corporation (hereafter, “CSTI”),
in exchange for 50,645,000 shares of common stock (the “TMGI Common Stock”) of the Company (such transaction is hereafter
referred to as the “Acquisition”). CSTI possesses a cloud-based, all-in-one golf
Filing page
SEC filing
Sculptor Diversified Real Estate Income Trust, Inc.
Sculptor Diversified Real Estate acquires JW Marriott Marco Island for $835M via $690M loan, $87M equity
Sculptor Diversified Real Estate Income Trust, Inc.
May 7, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 2.03, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
in 1982 and renovated in 2016) and the Lanai Tower (built in 2019). The MIH JV acquired a fee simple interest in the Property. The aggregate purchase price for the Property was $835.0 million. The acquisition was funded with $690 million of proceeds from the Loan (defined below) and the remainder from equity contributions from the members of the MIH JV (approximately
Filing page
SEC filing
OTLC
Oncotelic completes merger transferring patent portfolio to Lunai for $20M Series B Preferred stock
Oncotelic Therapeutics, Inc.
May 5, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
greement and Plan of Merger (the “Merger Agreement”) with Lunai Bioworks, Inc., a Delaware corporation (“Lunai”),
Lunai Bioworks IP, Inc., a Delaware corporation and a wholly owned subsidiary of Lunai (“Merger Sub”), Neurobridge IP Holdings
Filing page
SEC filing
IVHI
Invech buys sportypick.com sports betting platform for 5M restricted shares of IVHI stock
Invech Holdings, Inc.
April 23, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 8.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
has agreed to sell and the Company has agreed to purchase the website and total code of the sports betting platform
www.sportypick.com owned by Day (the “Assets”) in exchange for 5,000,000 restricted shares of common stock of the Company
(the “Shares”). The foregoing information is a summary of the
APA involved in the transaction described above, is not complete,
Filing page
SEC filing
VWAV
VisionWave acquires xClibre AI video IP for 7M shares + $6M note; $60M valuation
VisionWave Holdings, Inc.
April 13, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 9.01, 8.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
Company”) entered into an Asset Purchase Agreement (the “Agreement”) with Dream America Marketing Services, Ltda.,
a Costa Rican company (the “Seller”). Pursuant to the Agreement, the Company agreed to acquire
Filing page
SEC filing
PHGE
BiomX acquires ZorroNet, enters AI defense with $1.25M note and stock
BiomX Inc.
April 10, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 9.01
same event type: m_and_a
similar materiality
This filing
On September 9, 2025, Traws Pharma, Inc. (the “Company”) and Virom, Inc. (“Viriom”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company purchased certain assets (the “Purchased Assets”) from Viriom in exchange for $2,350,000 in cash (the “Purchase Price”), which was paid in full to Virom on September 9, 2025.
Comparable filing
active engagements with Elbit Systems Ltd (TASE/Nasdaq: ESLT) and other top
Israel’s preeminent defense prime contractors. As consideration, the Company issued to Water
IO: (i) 1,300,000 shares of common stock ; and (ii) a non-convertible promissory note in the amount of $1,250,000 , bearing
interest at the short-term applicable federal rate, payable July 7, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.